← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Innovative Biotherapies, Inc.
Ann Arbor, MI
$28,678,530
Total funding
21
Grants
Funding over time
peak $7.4M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$14,031,788 · 6
NIH$13,670,349 · 14
FDA$976,393 · 1
By mechanism
—$14,031,788 · 6
R44$9,932,986 · 5
R43$3,737,363 · 9
R01$976,393 · 1
Investigators at Innovative Biotherapies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
NANOFABRICATED BIOARTIFICAL KIDNEY$6,202,000
· FY2008 · Department of the Army
ASSESSMENT OF A THERAPEUTIC DEVICE FOR TREATMENT OF ACUTE LUNG INJURY USING A COMBAT-RELEVANT PORCINE MODEL$2,696,788
· FY2016 · Department of the Army
NANOFABRICATED BIO-ARTIFICIAL KIDNEY, PANCREAS AND LIVER$2,188,000
· FY2010 · Department of the Army
Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients$1,513,922
R44 · FY2025 · HL
DIABETES CARE IN THE MILITARY$1,398,000
· FY2011 · Department of the Army
Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients$1,314,026
R44 · FY2024 · HL
Enhanced Propagation of Adult Human Renal Epithelial Cells Allowing for Commercia$1,191,534
R44 · FY2010 · DK
Enhanced Propagation of Adult Human Renal Epithelial Cells Allowing for Commercia$961,915
R44 · FY2011 · DK
NANOFABRICATED BIOARTIFICIAL KIDNEY$848,000
· FY2009 · Department of the Army
Cell Therapy for Septic Shock$778,793
R44 · FY2008 · DK
Fiber design and assessment for development of a novel biomimetic medical device$763,998
R44 · FY2021 · TR
Selective Cytopheresis Therapy in Systemic Inflammatory Response Syndrome$739,631
R44 · FY2012 · TR
Cell Therapy for Septic Shock$717,906
R44 · FY2009 · DK
TRANSPORTABLE RENAL REPLACEMENT THERAPY FOR BATTLEFIELD APPLICATIONS$699,000
· FY2011 · Department of the Army
Selective Cytopheresis Therapy in Systemic Inflammatory Response Syndrome$692,609
R44 · FY2013 · TR
Biomimetic Membrane Device for Therapeutic Application in Chronic Heart Failure$655,205
R43 · FY2015 · HL
L-MOD Therapy: Leukocyte Immunomodulation during Cardiopulmonary Bypass$588,700
R43 · FY2015 · HL
Fiber design and assessment for development of a novel biomimetic medical device$563,353
R44 · FY2020 · TR
Fiber design and assessment for development of a novel biomimetic medical device$553,299
R44 · FY2022 · TR
Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury$399,483
R01 · FY2017 · FD